Screener / SEC EDGAR /CIK 0000097745 /10-K filed Feb 26, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
NYSE Health care · Measuring Instruments

Thermo Fisher Scientific TMO

Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. 10-K, Item 1

Employees
125,000
Headquarters
Waltham, MA
CEO
Marc N. Casper
Next results
around Jan 28, 2027
Compare with peers Embed

TMO among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 3.9%, above 27% of 59 peers (their median 7.2%) REVENUE GROWTH 3.9% · above 27% Operating margin: 17.9%, above 60% of 50 peers (their median 13.4%) OPERATING MARGIN 17.9% · above 60% Net margin: 14.9%, above 66% of 59 peers (their median 9.5%) NET MARGIN 14.9% · above 66% FCF margin: 16.0%, above 55% of 55 peers (their median 15.2%) FCF MARGIN 16.0% · above 55% Return on capital: 7.3%, above 24% of 41 peers (their median 9.2%) RETURN ON CAPITAL 7.3% · above 24%
TMO Peer median Below the median

What changed

2 new risk paragraphs. 10-K filed Feb 26, 2026 against Feb 20, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +8.7% vs revenue +3.9% (+4.7 pts)
  • Cash from operations $7.8B vs net income $6.7B (FY ending Dec 31, 2025)
  • Inventory +9.0% vs revenue +3.9% (+5.1 pts)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Income taxes
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

2 paragraphs in Risk Factors that were not in the 10-K filed Feb 20, 2025. Quoted as filed.

All 2 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 20, 2025 10-K, ITEM 1A
    We and our third-party providers experience cyber-attacks and other attempts to gain unauthorized access to our products, services, and systems and data on a regular basis, and we anticipate continuing to be subject to such attempts as cyber-attacks

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$44.9B$42.9B$42.9B$44.6B
Net income$7.0B$6.0B$6.3B$6.7B
Operating cash flow$9.2B$8.4B$8.7B$7.8B
Free cash flow$6.9B$6.9B$7.3B$6.3B

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$44.6B ▲ 3.9% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

4 filings in the last 30 days · SEC EDGAR

All filings

About the company

Thermo Fisher Scientific, Waltham, MA · from the 10-K filed Feb 26, 2026

Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings.

Headquarters
Waltham, MA
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 21, 2026
Incorporated in
DE

Employees, at the top of the page: "As of December 31, 2025, we employed approximately 125,000 colleagues globally, with an approximate regional distribution as follows: 59,000 based in the Americas, 22,000 in the Asia-Pacific region, and 44,000 in Europe, the Middle East and Africa (EMEA)" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 26, 2026 (open at SEC), compared with the 10-K filed Feb 20, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TMO/export.csv") into a cell.